Ge Healthcare Technologies Inc.
GE HealthCare Technologies Inc. Secures $1.4 Billion Financing for Intelerad Acquisition
Summary
On December 12, 2025, GE HealthCare Technologies Inc. entered into a $750 million senior unsecured term loan credit facility and issued $1.25 billion aggregate principal amount of senior notes due 2028 and 2035. The net proceeds from these financings, along with cash on hand, will be used to fund the acquisition of Intelerad Medical Systems. The term loan matures in three years, while the notes carry interest rates of 4.150% and 4.950% and mature in 2028 and 2035, respectively.
Profitelligence Alerts
Get alerts for GEHC
Be first to know when Ge Healthcare Technologies Inc. files with the SEC.
Filing Categories
Advertisement
About Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc. is a prominent player in the healthcare industry, focused on providing transformative medical technology and diagnostic solutions. Specializing in imaging, monitoring, and diagnostic equipment, the company plays a crucial role in enhancing clinical outcomes, improving patient care, and driving medical technology innovations. Ge Healthcare Technologies Inc. is recognized for its advancements in medical imaging systems, including MRI, CT, and ultrasound technologies, which aid in early disease detection and treatment planning. In addition to its hardware innovations, the company is actively involved in digital healthcare solutions, employing data analytics and AI to support precise diagnoses and personalized medicine. The impact of Ge Healthcare Technologies extends across various healthcare sectors, including hospitals, clinics, and research institutions, underscoring its importance in advancing clinical capabilities and operational efficiencies within the healthcare system. Ge Healthcare Technologies Inc. maintains a strategic presence in global markets, bolstering healthcare infrastructure and supporting public health initiatives. By continuously striving to innovate and improve healthcare delivery, it remains a significant entity within the broader medical technology and life sciences industry, contributing to the future of healthcare.
Official SEC Documents
Advertisement